198 related articles for article (PubMed ID: 24771263)
1. Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance.
Qi F; Liu Y; Zhao R; Zou X; Zhang L; Li J; Wang Y; Li F; Zou X; Xia Y; Wang X; Xing L; Li C; Lu J; Tang J; Zhou F; Liu C; Gui Y; Cai Z; Sun X
Tumour Biol; 2014 Jul; 35(7):7217-23. PubMed ID: 24771263
[TBL] [Abstract][Full Text] [Related]
2. Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder.
Hazzaa SM; Elashry OM; Afifi IK
Pathol Oncol Res; 2010 Mar; 16(1):101-9. PubMed ID: 19757199
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
4. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
[TBL] [Abstract][Full Text] [Related]
6. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
7. Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.
Passerotti CC; Srougi M; Bomfim AC; Martins JR; Leite KR; Dos Reis ST; Sampaio LO; Ortiz V; Dietrich CP; Nader HB
Urol Oncol; 2011; 29(6):710-5. PubMed ID: 19962919
[TBL] [Abstract][Full Text] [Related]
8. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
[TBL] [Abstract][Full Text] [Related]
9. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
Jamshidian H; Kor K; Djalali M
Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of folate receptor α-positive circulating tumour cells in gastric cancer.
Cao B; Liu L; Zhang R; Dong H; Shen J
Postgrad Med J; 2024 Jan; 100(1180):112-119. PubMed ID: 37973392
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
12. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis.
Msaouel P; Koutsilieris M
BMC Cancer; 2011 Aug; 11():336. PubMed ID: 21816094
[TBL] [Abstract][Full Text] [Related]
14. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
[TBL] [Abstract][Full Text] [Related]
15. The role of serum laminin P1 in the diagnosis of transitional cell carcinoma of the bladder.
Abou Farha KM; Menheere PP; Bruins JL; Kester AD; Janknegt R
Eur Urol; 1992; 21(3):240-4. PubMed ID: 1499633
[TBL] [Abstract][Full Text] [Related]
16. LASP-1, a novel urinary marker for detection of bladder cancer.
Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.
Heicappell R; Schostak M; Müller M; Miller K
Scand J Clin Lab Invest; 2000 Jul; 60(4):275-82. PubMed ID: 10943597
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
Lin YL; Sun G; Liu XQ; Li WP; Ma JG
J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
[TBL] [Abstract][Full Text] [Related]
19. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
[TBL] [Abstract][Full Text] [Related]
20. [Detection of circulating tumor cells from peripheral blood in patients with transitional cell carcinoma--pilot study. Comparison with the standard histopathological staging].
Nagy V; Rosocha J; Zidzik J; Bohus P
Klin Onkol; 2011; 24(4):287-92. PubMed ID: 21905620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
